These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9049966)

  • 21. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function.
    Wolk K; Mitsui H; Witte K; Gellrich S; Gulati N; Humme D; Witte E; Gonsior M; Beyer M; Kadin ME; Volk HD; Krueger JG; Sterry W; Sabat R
    Clin Cancer Res; 2014 Nov; 20(21):5507-16. PubMed ID: 25212608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. About the cutaneous targets of bexarotene in CTCL patients.
    Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
    Exp Dermatol; 2010 Aug; 19(8):e299-301. PubMed ID: 19845753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant T cells in cutaneous T-cell lymphoma lesions contain decreased levels of the antiapoptotic protein Ku70.
    Ferenczi K; Ohtola J; Aubert P; Kessler M; Sugiyama H; Somani AK; Gilliam AC; Chen JZ; Yeh I; Matsuyama S; McCormick TS; Cooper KD
    Br J Dermatol; 2010 Sep; 163(3):564-71. PubMed ID: 20408834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
    Cetinözman F; Jansen PM; Willemze R
    Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells.
    Zhang CL; Kamarashev J; Qin JZ; Burg G; Dummer R; Döbbeling U
    J Pathol; 2003 Jun; 200(2):249-54. PubMed ID: 12754746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of immunohistologic analysis in differentiating cutaneous T-cell lymphoma from psoriasis and dermatitis.
    Verga M; Braverman IM
    Arch Dermatol; 1991 Oct; 127(10):1503-10. PubMed ID: 1929457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors.
    Sarris AH; Broxmeyer HE; Wirthmueller U; Karasavvas N; Cooper S; Lu L; Krueger J; Ravetch JV
    J Exp Med; 1993 Sep; 178(3):1127-32. PubMed ID: 8350051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
    Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased angiogenesis in cutaneous T-cell lymphomas.
    Mazur G; Woźniak Z; Wróbel T; Maj J; Kuliczkowski K
    Pathol Oncol Res; 2004; 10(1):34-6. PubMed ID: 15029259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
    Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
    Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Fujita H; Ohmatsu H; Kakinuma T; Kadono T; Tamaki K; Sato S
    J Invest Dermatol; 2010 Sep; 130(9):2304-11. PubMed ID: 20505746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCA-1, A B-cell chemoattractant signal, is constantly expressed in cutaneous lymphoproliferative B-cell disorders.
    Mori M; Manuelli C; Pimpinelli N; Bianchi B; Orlando C; Mavilia C; Cappugi P; Maggi E; Giannotti B; Santucci M
    Eur J Cancer; 2003 Jul; 39(11):1625-31. PubMed ID: 12855271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour necrosis factor-alpha but not interferon-gamma is the main inducer of inducible protein-10 in skin fibroblasts from patients with atopic dermatitis.
    Villagomez MT; Bae SJ; Ogawa I; Takenaka M; Katayama I
    Br J Dermatol; 2004 May; 150(5):910-6. PubMed ID: 15149503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous T-cell lymphoma sparing resolving dermatomal herpes zoster lesions: an unusual phenomenon and implications for pathophysiology.
    Twersky JM; Nordlund JJ
    J Am Acad Dermatol; 2004 Jul; 51(1):123-6. PubMed ID: 15243537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin.
    Kaplan G; Luster AD; Hancock G; Cohn ZA
    J Exp Med; 1987 Oct; 166(4):1098-108. PubMed ID: 2443597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.
    Sommer VH; Clemmensen OJ; Nielsen O; Wasik M; Lovato P; Brender C; Eriksen KW; Woetmann A; Kaestel CG; Nissen MH; Ropke C; Skov S; Ødum N
    Leukemia; 2004 Jul; 18(7):1288-95. PubMed ID: 15141228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous T-cell lymphoma in association with silicone breast implants.
    Duvic M; Moore D; Menter A; Vonderheid EC
    J Am Acad Dermatol; 1995 Jun; 32(6):939-42. PubMed ID: 7751462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.